EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access

Haematologic biomarkers and survival in gallbladder cancer: a systematic review and meta-analysis

Rogelio N Velasco, Harold Nathan C Tan, Michael D San Juan

ecancermedicalscience · 30.01.2024 · 18

DOI: 10.3332/ecancer.2024.1660 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ecancermedicalscience, online erschienen am 30.01.2024. Verfasst von Rogelio N Velasco und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial and Research Division, Philippine Heart Center, Quezon City 0850, Philippines. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gallbladder cancer is a rare malignancy characterised by poor survival with lack of durable response to treatment. Thus, novel biomarkers are needed to prognosticate patients. This systematic review and meta-analysis sought to examine the role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet count (PC) and serum immune inflammation index in predicting the survival of patients with gallbladder cancer. Materials and methods: A systematic search was done using PubMed, Cochrane, ClinicalTrials.gov and Google Scholar for articles published from inception until 8 February 2022. Hazard ratios (HR) with 95% confidence intervals (CI) were pooled and subgroup analyses were conducted according to treatment, region and cut-offs. The primary outcome of interest was overall survival (OS). Data were summarised using RevMan version 5.4.

Results

Twenty studies comprising 5,183 patients were included in the analysis. High neutrophil-lymphocyte ratio (HR 1.72, 95% CI 1.47-2.02), platelet-lymphocyte ratio (HR 1.51, 95% CI 1.33-1.72), monocyte-lymphocyte ratio (HR 1.96, 95% CI 1.46-1.64), PC (HR 1.20, 95% CI 1.02-1.40) and serum inflammation index (HR 1.73, 95% CI 1.36-2.18) were all associated with worse survival. The association was consistent across most subgroups on race and cut-offs with a trend towards poor survival for PC above 252.5.

Conclusion

High neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, monocyte-lymphocyte ratio, PC and SII are associated with worse OS in gallbladder cancer and are potential biomarkers for prognostication. Prospective studies are recommended to further evaluate their use.

Schlagwörter

Stichwörter der Autor:innen

gallbladder neoplasmsinflammationsurvival

Autor:innen und Institutionen

  • Clinical Trial and Research Division, Philippine Heart Center, Quezon City 0850, Philippines.
  • Lung Center of the Philippines, Quezon City 1101, Philippines.
  • Section of Medical Oncology, Makati Medical Center, Makati City 1229, Philippines.
  • Division of Medical Oncology, Philippine General Hospital, Manila 1000, Philippines.

Zitieren

APA

Velasco, R. N., Tan, H. N. C., & Juan, M. D. S. (2024). Haematologic biomarkers and survival in gallbladder cancer: a systematic review and meta-analysis. ecancermedicalscience, 18. https://doi.org/10.3332/ecancer.2024.1660

Vancouver

Velasco RN, Tan HNC, Juan MDS. Haematologic biomarkers and survival in gallbladder cancer: a systematic review and meta-analysis. ecancermedicalscience. 2024;18. doi:10.3332/ecancer.2024.1660

BibTeX
@article{Velasco2024,
  author = {Velasco, Rogelio N and Tan, Harold Nathan C and Juan, Michael D San},
  title = {Haematologic biomarkers and survival in gallbladder cancer: a systematic review and meta-analysis},
  journal = {ecancermedicalscience},
  year = {2024},
  volume = {18},
  doi = {10.3332/ecancer.2024.1660}
}
Kostenlos starten →